• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

American Society of Clinical Oncology (ASCO) - Articles and news items

APR-246

Aprea announces efficacy and safety data for APR-246 in ovarian cancer

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Aprea presented clinical data from the Phase Ib part of the ongoing PiSARRO Phase Ib/II trial of APR-246 at the ASCO annual meeting…

tafinlar

Novartis presents new data for Tafinlar + Mekinist at ASCO

Industry news / 7 June 2016 / Victoria White, Digital Content Producer

Novartis has announced new data for the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) in non-small cell lung cancer (NSCLC) and melanoma…

IMCgp100

Positive Phase I data for IMCgp100 in metastatic melanoma

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Immunocore has announced positive data from the first in human, Phase I clinical trial of its lead ImmTAC, IMCgp100…

keytruda

Merck releases new data for Keytruda at ASCO

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Keytruda is a humanised monoclonal antibody that works by increasing the ability of the body’s immune system to help detect and fight tumour cells…

IMAB362

IMAB362 extends survival in gastric cancer

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Ganymed announced data from its randomised Phase II clinical study of IMAB362 in first-line treatment of gastric cancer at the ASCO 2016 Annual Meeting…

nsclc

Data for Alimta and Cyramza plus keytruda in NSCLC presented at ASCO

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Data were presented from two early-phase trials evaluating Lilly’s Alimta and Cyramza in combination with Merck’s Keytruda in patients with NSCLC…

opdivo

BMS presents new data for Opdivo at ASCO

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

New data for Bristol-Myers Squibb’s Opdivo has been presented at the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)…

daratumumab

Daratumumab extends PFS in patients with multiple myeloma

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

Daratumumab, in combination with bortezomib and dexamethasone, demonstrated a 61% reduction in the risk of disease progression or death…

boehringer ingelheim

Boehringer Ingelheim at ASCO: Oncology and Innovation

Blog, Z Homepage promo / 6 June 2016 / Victoria White, Digital Content Producer

We recently caught up with Dr Jörg Barth, Boehringer Ingelheim, to find out more about the company’s oncology pipeline and presence at ASCO….

sarcoma-Trabectedin

Trabectedin shown to improve disease control in patients with advanced soft tissue sarcoma

Industry news / 3 June 2015 / Victoria White

Janssen Research & Development has announced data from a Phase 3 study of trabectedin (YONDELIS) in patients with two common types of soft tissue sarcoma…

cancer-veliparib

AbbVie presents Phase 2 results from study of veliparib in patients with NSCLC who are current smokers

Industry news / 3 June 2015 / Victoria White

AbbVie has announced findings from a Phase 2 study of a veliparib regimen in patients with non-small cell lung cancer (NSCLC) who are current smokers…

prostate-cancer-cabazitaxel

Cabazitaxel – carboplatin combination chemotherapy holds promise as treatment for advanced prostate cancer

Industry news / 1 June 2015 / Victoria White

A new study compared the effectiveness of cabazitaxel alone versus cabazitaxel combined with carboplatin in patients with mCRPC…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +